التفاصيل البيبلوغرافية
| العنوان: |
One-way sensitivity analysis for the incremental cost-effectiveness ratio (ICER) of (a) annual universal screening starting at age 30 years and (b) annuals screening of individuals with diabetes, compared with the status quo without CUSUMGFR -based screening with parameter values varying within a range of 25% of the baseline value. |
| المؤلفون: |
Reyhaneh Zafarnejad, Qiushi Chen, Paul M. Griffin |
| سنة النشر: |
2024 |
| المجموعة: |
Smithsonian Institution: Figshare |
| مصطلحات موضوعية: |
Medicine, Biotechnology, Sociology, Marine Biology, Infectious Diseases, total discounted disability, sodium &# 8211, probabilistic sensitivity analyses, direct health costs, basic blood test, adjusted life years, 60 years ), influential model parameters, cumulative sum statistic, recent treatment option, chronic kidney disease, testing cost resulted, patients ’ awareness, considered four cusum, ckd progression rate, universal annual screening, estimated incremental cost, disease progression, incremental cost, microsimulation model, cumulative egfr, treatment regimen, disease monitoring, highly cost, united states |
| الوصف: |
One-way sensitivity analysis for the incremental cost-effectiveness ratio (ICER) of (a) annual universal screening starting at age 30 years and (b) annuals screening of individuals with diabetes, compared with the status quo without CUSUMGFR -based screening with parameter values varying within a range of 25% of the baseline value. |
| نوع الوثيقة: |
still image |
| اللغة: |
unknown |
| Relation: |
https://figshare.com/articles/figure/One-way_sensitivity_analysis_for_the_incremental_cost-effectiveness_ratio_ICER_of_a_annual_universal_screening_starting_at_age_30_years_and_b_annuals_screening_of_individuals_with_diabetes_compared_with_the_status_quo_without_CUSUMGFR_-base/25401105 |
| DOI: |
10.1371/journal.pone.0299401.g003 |
| الاتاحة: |
https://doi.org/10.1371/journal.pone.0299401.g003 |
| Rights: |
CC BY 4.0 |
| رقم الانضمام: |
edsbas.8C805B4 |
| قاعدة البيانات: |
BASE |